Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Doctor tells committee spike protein can cause microvascular clots; describes outpatient anticoagulation approach
Summary
Dr. Jordan Vaughn told a special committee that the SARS‑CoV‑2 spike protein can trigger microvascular coagulation and damage the endothelium, described outpatient anticoagulation and antiplatelet regimens he says helped many patients, and raised concerns about vaccine mechanisms and regulatory incentives.
Dr. Jordan Vaughn, an internist who said he runs a large private practice in Alabama, told the Special Committee on COVID Response Efficacy that the SARS‑CoV‑2 spike protein "is damaging to the vessels and and causes coagulation issues," and described microscopic fibrin abnormalities he said are resistant to normal fibrinolysis.
Vaughn testified that the clotting he sees is different in kind from ordinary thrombi and that, whether produced by infection or by vaccination, the spike protein can cause protein confirmations that make fibrin harder to break down. "The spike protein itself, regardless of its source, is is damaging to the vessels and and causes coagulation issues," he said. He pointed to work by clinicians in South Africa and the University of Liverpool and…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
